Jonathan Trinh

DTC Reforms And MAHA Proclamations: The MAHA Agenda And Its Focus On Prescription Drugs Continues To Take Shape

Transparency So Radical It Overlooks Law And Tradition: FDA Releases Complete Response Letters For Unapproved Drugs

FDA Begins To Accept Nominations For The Commissioner's National Priority Voucher Pilot Program

FDA Issues Final Guidance Addressing Remote Regulatory Assessments

FDA Announces Commissioner's National Priority Vouchers To Facilitate Expedited Access To Certain Drugs